These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 31601677)

  • 1. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
    Shi Y; Manis M; Long J; Wang K; Sullivan PM; Remolina Serrano J; Hoyle R; Holtzman DM
    J Exp Med; 2019 Nov; 216(11):2546-2561. PubMed ID: 31601677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
    Chen X; Firulyova M; Manis M; Herz J; Smirnov I; Aladyeva E; Wang C; Bao X; Finn MB; Hu H; Shchukina I; Kim MW; Yuede CM; Kipnis J; Artyomov MN; Ulrich JD; Holtzman DM
    Nature; 2023 Mar; 615(7953):668-677. PubMed ID: 36890231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
    Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
    Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms.
    Shi Y; Andhey PS; Ising C; Wang K; Snipes LL; Boyer K; Lawson S; Yamada K; Qin W; Manis M; Serrano JR; Benitez BA; Schmidt RE; Artyomov M; Ulrich JD; Holtzman DM
    Neuron; 2021 Aug; 109(15):2413-2426.e7. PubMed ID: 34157306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intersection of pathological tau and microglia at the synapse.
    Vogels T; Murgoci AN; Hromádka T
    Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy.
    Seo DO; O'Donnell D; Jain N; Ulrich JD; Herz J; Li Y; Lemieux M; Cheng J; Hu H; Serrano JR; Bao X; Franke E; Karlsson M; Meier M; Deng S; Desai C; Dodiya H; Lelwala-Guruge J; Handley SA; Kipnis J; Sisodia SS; Gordon JI; Holtzman DM
    Science; 2023 Jan; 379(6628):eadd1236. PubMed ID: 36634180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration.
    Galán-Ganga M; Rodríguez-Cueto C; Merchán-Rubira J; Hernández F; Ávila J; Posada-Ayala M; Lanciego JL; Luengo E; Lopez MG; Rábano A; Fernández-Ruiz J; Lastres-Becker I
    Acta Neuropathol Commun; 2021 May; 9(1):90. PubMed ID: 34001284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau.
    Kang SS; Ebbert MTW; Baker KE; Cook C; Wang X; Sens JP; Kocher JP; Petrucelli L; Fryer JD
    J Exp Med; 2018 Sep; 215(9):2235-2245. PubMed ID: 30082275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineuronal net deglycosylation associates with tauopathy-induced gliosis and neurodegeneration.
    Logsdon AF; Foresi B; Hu SJ; Quah E; Meuret CJ; Le JP; Hendrickson AS; Redford IK; Kumar A; Phan BA; Doan TP; Noonan C; Hendricks NE; Wheeler JM; Kraemer BC; Alonge KM
    J Neurochem; 2024 Sep; 168(9):1923-1936. PubMed ID: 38317026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
    Front Immunol; 2020; 11():997. PubMed ID: 32508844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
    Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB
    Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
    Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
    Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 aggravates microglial activation and tau transmission in tauopathy.
    Siew JJ; Chen HM; Chiu FL; Lee CW; Chang YM; Chen HL; Nguyen TNA; Liao HT; Liu M; Hagar HT; Sun YC; Lai HL; Kuo MH; Blum D; Buée L; Jin LW; Chen SY; Ko TM; Huang JR; Kuo HC; Liu FT; Chern Y
    J Clin Invest; 2024 Jan; 134(2):. PubMed ID: 37988169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models.
    Ma QL; Zhu C; Morselli M; Su T; Pelligrini M; Lu Z; Jones M; Denver P; Castro D; Gu X; Relampagos F; Caoili K; Teter B; Frautschy SA; Cole GM
    Front Immunol; 2020; 11():558036. PubMed ID: 33178186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
    Siman R; Cocca R; Dong Y
    PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration.
    Engstrom AK; Walker AC; Moudgal RA; Myrick DA; Kyle SM; Bai Y; Rowley MJ; Katz DJ
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29133-29143. PubMed ID: 33139560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy.
    Sahara N; Maeda J; Ishikawa A; Tokunaga M; Suhara T; Higuchi M
    J Alzheimers Dis; 2018; 64(s1):S353-S359. PubMed ID: 29865054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.